UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder
This study provides real-world evidence supporting the potential of CBMPs for improving GAD symptoms. Patients prescribed both oil-based and dried flower formulations have similar outcomes over 12 months. Further research is needed to determine the optimal CBMP formulation and long-term effects.
Authors
- Fatema Kamal (ORCID: https://orcid.org/0000-0003-2253-7397)
- Urmila Bhoskar
- Ross Coomber (ORCID: https://orcid.org/0000-0002-8144-1996)
- Simon Erridge (ORCID: https://orcid.org/0000-0001-5871-6501)
- Laura Korb (ORCID: https://orcid.org/0000-0002-0084-1665)
- James Rucker (ORCID: https://orcid.org/0000-0003-4647-8088)
- Gracia Mwimba
- Muhammad Imran (ORCID: https://orcid.org/0000-0002-0126-8311)
- Kaitlyn McLachlan (ORCID: https://orcid.org/0000-0003-4569-7529)
- Mikael H. Sodergren (ORCID: https://orcid.org/0000-0002-7141-3924)
- Gabriel Shaya
- Muhammad Sohaib Asghar (ORCID: https://orcid.org/0000-0001-6705-2030)
- Eleanor Clarke (ORCID: https://orcid.org/0000-0002-2150-2283)
- Simmi Sachdeva-Mohan
- Matthieu Crews
- John Warner‐Levy (ORCID: https://orcid.org/0000-0003-2632-7266)
- Andrea De Angelis (ORCID: https://orcid.org/0000-0003-4320-7194)
- Karl Bexley
Institutions
- St George's Hospital (GB)
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- University of Manchester (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Expert Review of Neurotherapeutics
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1080/14737175.2024.2423634
- Citations
- 4
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.79